Click here to invite colleagues to join the Forum for FREE Home  |  About  |  PCSK9  |  News  |  Commentary  |  Trials  |  Videos  |  Resources  |  Contact 2016 ACC Scientific Sessions News ACC 2016: Latebreaker underscores the value of genetic testing in ascertaining coronary risk in FH  A key paper for the familial hypercholesterolaemia (FH, inherited high cholesterol) community was presented at the clinical Latebreaker session. According to PCSK9 Forum Board member, Professor Gerald Watts, University of Western Australia, Perth, Australia, the paper by Khera and co-workers not only confirms the higher prevalence of FH, as reported recently, but also shows that FH is most efficiently diagnosed with both LDL cholesterol and DNA testing. Read the full article » New and updated edition of our popular therapeutic guide A second edition of the free introductory guide: PCSK9 Inhibition - New Therapies in Cardiovascular Risk Reduction is now available on the Forum’s website. This very popular book has been updated with the latest information discussing the biology and therapeutic potential of PCSK9 inhibition. As you know, this downloadable e-book is freely available to all registered members of the Forum. Read online » Download now » Forward to colleagues » Questions & Answers Inhibition of PCSK9 offers the real possibility of improved management of high-risk patients. Read the full answer and other questions on the PCSK9 Forum » Like us on Facebook For the latest updates, PCSK9 news and analysis. Follow us on Twitter Hot topics, news and conference reports. YouTube Channel For videos, interviews and webcasts from leading experts. Educational Partners and Supporters Copyright PCSK9 Forum 2016. Please click here to unsubscribe from future mailings.